CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. (Q51073063)
Jump to navigation
Jump to search
scientific article published on 21 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. |
scientific article published on 21 March 2014 |
Statements
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. (English)
1 reference
Thomas O Bergmeijer
1 reference
Paul W A Janssen
1 reference
Jurjan C Schipper
1 reference
Khalid Qaderdan
1 reference
Maycel Ishak
1 reference
Rianne S Ruitenbeek
1 reference
Arnoud W J van 't Hof
1 reference
Willem J M Dewilde
1 reference
Fabrizio Spanó
1 reference
Jean-Paul R Herrman
1 reference
Johannes C Kelder
1 reference
Maarten J Postma
1 reference
Anthonius de Boer
1 reference
Vera H M Deneer
1 reference
Jurriën M ten Berg
1 reference
21 March 2014
1 reference
168
1 reference
1
1 reference
16-22.e1
1 reference
Identifiers
1 reference